Literature DB >> 15513378

Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease.

N Yoshida1, K Uchiyama, M Kuroda, K Sakuma, S Kokura, H Ichikawa, Y Naito, T Takemura, T Yoshikawa, T Okanoue.   

Abstract

BACKGROUND: It has been reported that inflammatory cell infiltration can be detected in patients with endoscopically negative gastroesophageal reflux disease (GERD) as well as those with erosive reflux esophagitis. In this study, we examined the expression of mRNA for interleukin (IL)-8, a potent chemokine for neutrophils, in the esophageal mucosa of patients with GERD and compared the results with their endoscopic findings and symptoms.
METHODS: Biopsy samples were obtained from 80 patients. Endoscopic diagnosis was performed according to the Los Angeles classification. Patients with typical symptoms such as heartburn despite normal endoscopic findings were classified as the non-erosive GERD group. Total cellular RNA was extracted from the biopsy samples and IL-8 mRNA was quantified by real-time polymerase chain reaction (PCR). Localization of IL-8 protein in the esophageal mucosa was done by immunostaining.
RESULTS: Expression of IL-8 mRNA was correlated with the endoscopic grade of esophagitis or with inflammatory cell infiltration, but not with the symptoms of the patients. Expression of IL-8 mRNA was also detected in all patients with non-erosive GERD. The level of IL-8 expression in non-erosive GERD was low compared with that in erosive GERD, but was higher than that in normal controls. IL-8 immunostaining was found in the basal layers of the esophageal mucosa. Administration of lansoprazole, a proton-pump inhibitor, decreased both IL-8 mRNA and protein levels in the esophageal mucosa.
CONCLUSION: These results suggest that IL-8 in the esophageal mucosa may be involved in the pathogenesis of esophageal inflammation, including non-erosive GERD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15513378     DOI: 10.1080/00365520410006729

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  37 in total

Review 1.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

2.  Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.

Authors:  Olga Chemnitzer; Katharina Götzel; Luisa Maurer; Arne Dietrich; Uwe Eichfeld; Orestis Lyros; Boris Jansen-Winkeln; Albrecht Hoffmeister; Ines Gockel; René Thieme
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

Review 3.  Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.

Authors:  Florian Rieder; Piero Biancani; Karen Harnett; Lisa Yerian; Gary W Falk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

Review 4.  Microbiome, innate immunity, and esophageal adenocarcinoma.

Authors:  Jonathan Baghdadi; Noami Chaudhary; Zhiheng Pei; Liying Yang
Journal:  Clin Lab Med       Date:  2014-09-26       Impact factor: 1.935

5.  Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls.

Authors:  A Altomare; J Ma; M P L Guarino; L Cheng; F Rieder; M Ribolsi; C Fiocchi; P Biancani; K Harnett; M Cicala
Journal:  Neurogastroenterol Motil       Date:  2012-06-26       Impact factor: 3.598

6.  Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later.

Authors:  Mark Noar; Patrick Squires; Emmanuelle Noar; Martin Lee
Journal:  Surg Endosc       Date:  2014-02-22       Impact factor: 4.584

7.  Prevention by rebamipide of acute reflux esophagitis in rats.

Authors:  Kazuhiro Katada; Norimasa Yoshida; Yutaka Isozaki; Naoya Tomatsuri; Hiroshi Ichikawa; Yuji Naito; Takeshi Okanoue; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

8.  TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells.

Authors:  Diana M Lim; Sneha Narasimhan; Carmen Z Michaylira; Mei-Lun Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

9.  The expression of heme oxygenase-1 induced by lansoprazole.

Authors:  Tomohisa Takagi; Yuji Naito; Toshikazu Yoshikawa
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114

10.  Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa.

Authors:  Karen M Harnett; Florian Rieder; Jose Behar; Piero Biancani
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.